BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3054757)

  • 1. [Effect of fosfomycin on cellular immune reactions as affected by cyclophosphamide or corticosteroids].
    Gillissen G; Breuer-Werle M; Ostendorp H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):731-4. PubMed ID: 3054757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
    Ahlstedt S
    Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cefaclor on immune response parameters.
    Gillissen G
    Arzneimittelforschung; 1984; 34(11):1535-40. PubMed ID: 6335399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased resistance towards two systemic experimental infections by tetrachlorodecaoxygen anion complex. Possible implications of cellular and humoral immunity.
    Gillissen G; Kühne FW; Breuer-Werle M; Melzer B; Ostendorp H
    Arzneimittelforschung; 1986 Dec; 36(12):1778-82. PubMed ID: 3566839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Inverse" effects of cortisone in experimental infection of mice.
    Gillissen G
    Adv Exp Med Biol; 1992; 319():137-43. PubMed ID: 1414589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
    Mokyr MB; Dray S
    Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose cyclophosphamide inhibition of transplantable fibrosarcoma growth by augmentation of the host immune response.
    Ray PK; Raychaudhuri S
    J Natl Cancer Inst; 1981 Dec; 67(6):1341-5. PubMed ID: 6947115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of sheep erythrocyte (SRBC)-induced pleurisy in non-sensitized mice by cyclophosphamide: demonstration of natural cell-mediated immune reactivity to SRBC.
    Yamamoto S; Higuchi Y; Teshima H
    Immunology; 1982 Sep; 47(1):31-40. PubMed ID: 7118162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant mouse model of E. coli diarrhoea: clinical protection induced by vaccination of the mothers.
    Duchet-Suchaux M
    Ann Rech Vet; 1983; 14(3):319-31. PubMed ID: 6362544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Schiffman G
    Cancer Res; 1981 Mar; 41(3):801-7. PubMed ID: 7459867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F; Marić M; Morović-Vergles J
    In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
    Artym J; Zimecki M; Kruzel ML
    Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 16. [Additive effect of an immunomodulator on the therapeutic effect of antibiotics].
    Gillissen G; Breuer-Werle M
    Pathol Biol (Paris); 1983 Jun; 31(6):548-50. PubMed ID: 6348668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
    Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
    J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D; Cameron AE
    Int J Tissue React; 1984; 6(3):205-11. PubMed ID: 6480267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.
    Lagrange PH; Michel JC; Hurtrel B; Thickstun PM
    Ann Immunol (Paris); 1980; 131C(3):257-77. PubMed ID: 7406440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.